Regulatory in brief | NSAIDs, codeine, CMDh

22 October 2020 - Deborah Wilkes

Archived

The US Food and Drug Administration (FDA) has implemented labelling changes for non-steroidal anti-inflammatory drugs (NSAIDs), New Zealand has confirmed the date for reverse-switching all medicines containing codeine from non-prescription to prescription status, and Europe's Coordination Group for Mutual Recognition and Decentralised Procedures for Humans (CMDh) has a new chair.

Click tags below for more information on topics:

FDA Codeine

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: